4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-18-001466
Chief Operating Officer sold 20,000 shares at $3.69 ($73,800)
- Chief Operating Officer acquired 175,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
GIVEN BRUCE D · Chief Operating Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-01-01 | Grant or award : show line 1 in the form | +175,000 | 948,356 | D | ||
| 2018-01-01 | Sale : show line 2 in the form | −20,000 | $3.69 | $73,800 | 928,356 | D |
| Open-market sales · 20,000 sh · avg $3.69 · $73,800 | ||||||
Loading xslF345X03/doc4.xml…